Zobrazeno 1 - 10
of 364
pro vyhledávání: '"van de Merbel N"'
Autor:
Pouwels, S.D., Klont, F., Van De Merbel, N., Horvatovich, P., Ten Hacken, N.H.T., Bischoff, R.
Publikováno v:
American Journal of Respiratory and Critical Care Medicine, 195:C73. AMER THORACIC SOC
Rationale: Soluble RAGE (sRAGE) is a promising biomarker for COPD and an attractive target for biomarker validation studies. Validated, reliable and clinically applicable biomarkers are needed for the early detection of COPD, identification of clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::df2d86bd36bda1fe7023f1b242d28dfa
https://research.rug.nl/en/publications/c4651958-65c4-4935-8d19-b2048813dc41
https://research.rug.nl/en/publications/c4651958-65c4-4935-8d19-b2048813dc41
Autor:
Spanov B; Department of Analytical Biochemistry, Groningen Research Institute of Pharmacy, University of Groningen, A Deusinglaan 1, 9713 AV Groningen, the Netherlands., Olaleye O; Department of Analytical Biochemistry, Groningen Research Institute of Pharmacy, University of Groningen, A Deusinglaan 1, 9713 AV Groningen, the Netherlands., Lingg N; Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Muthgasse 18, A-1190 Vienna, Austria., Bentlage AEH; Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, the Netherlands., Govorukhina N; Department of Analytical Biochemistry, Groningen Research Institute of Pharmacy, University of Groningen, A Deusinglaan 1, 9713 AV Groningen, the Netherlands., Hermans J; Department of Analytical Biochemistry, Groningen Research Institute of Pharmacy, University of Groningen, A Deusinglaan 1, 9713 AV Groningen, the Netherlands., van de Merbel N; Department of Analytical Biochemistry, Groningen Research Institute of Pharmacy, University of Groningen, A Deusinglaan 1, 9713 AV Groningen, the Netherlands; Bioanalytical Laboratory, PRA Health Sciences, Early Development Services, Westerbrink 3, 9405 BJ Assen, the Netherlands., Vidarsson G; Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, the Netherlands., Jungbauer A; Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Muthgasse 18, A-1190 Vienna, Austria., Bischoff R; Department of Analytical Biochemistry, Groningen Research Institute of Pharmacy, University of Groningen, A Deusinglaan 1, 9713 AV Groningen, the Netherlands. Electronic address: r.p.h.bischoff@rug.nl.
Publikováno v:
Journal of chromatography. A [J Chromatogr A] 2021 Oct 11; Vol. 1655, pp. 462506. Date of Electronic Publication: 2021 Aug 28.
Autor:
Timmerman P; European Bioanalysis Forum, 1000, Brussels, Belgium., Barfield M; Roche Pharma Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F Hoffmann-La Roche Ltd, 4070, Basel, Switzerland., Cowan K; Merck KGaA, New Biological Entities Drug Metabolism & Pharmacokinetics, 64293, Darmstadt, Germany., Golob M; Nuvisan GmbH, Bioanalysis, 89231, Neu-Ulm, Germany., Goodman J; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB21 6GH, UK., Kunz U; Boehringer Ingelheim Pharma GmbH & Co. KG, Translational Medicine & Clinical Pharmacology, 88400, Biberach ad Riss, Germany., Laurén A; Non-clinical & Clinical Assay Sciences, Global Discovery & Development Sciences, Global Drug Discovery, Novo Nordisk A/S, DK-2760, Måløv, Denmark., Love I; Charles River Laboratories, Department of Chromatographic Bioanalysis, EH33 2NE, Edinburgh, UK., Nelson R; Labcorp Drug Development, Scientific Affairs, 1217, Meyrin, Switzerland., Staack RF; Roche Pharma Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center Munich, Roche Diagnostics GmbH, 82377, Penzberg, Germany., Stanta J; Freeline Therapeutics, Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, SG1 2FX, UK., van de Merbel N; Icon, Bioanalytical Laboratory, 9407, TK, Assen, The Netherlands., Wilson A; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB22 3AT, UK.
Publikováno v:
Bioanalysis [Bioanalysis] 2021 Oct; Vol. 13 (19), pp. 1459-1465. Date of Electronic Publication: 2021 Oct 04.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pils, Marlene1,2 (AUTHOR), Dybala, Alexandra3 (AUTHOR), Schaffrath, Anja1 (AUTHOR), Rehn, Fabian1,2 (AUTHOR), Kutzsche, Janine1 (AUTHOR), Blömeke, Lara1 (AUTHOR), Tusche, Markus1 (AUTHOR), Özdüzenciler, Pelin1 (AUTHOR), Bujnicki, Tuyen1 (AUTHOR), Kraemer-Schulien, Victoria1 (AUTHOR), Gramespacher, Hannes4 (AUTHOR), Schmieschek, Maximilian H.T.4 (AUTHOR), Barbe, Michael T.4 (AUTHOR), Onur, Oezguer A.4,5 (AUTHOR), Fink, Gereon R.4,5 (AUTHOR), Tamgüney, Gültekin1,3 (AUTHOR), Bannach, Oliver1,2 (AUTHOR), Willbold, Dieter1,2,3 (AUTHOR) d.willbold@fz-juelich.de
Publikováno v:
Alzheimer's Research & Therapy. 10/14/2024, Vol. 16 Issue 1, p1-15. 15p.
Autor:
Poelman, E., Hoogeveen–Westerveld, M., Kroos-de Haan, M., van den Hout, J., Bronsema, K., van de Merbel, N., van der Ploeg, A., Pijnappel, W.
Publikováno v:
In Neuromuscular Disorders October 2017 27 Supplement 2:S162-S162
Autor:
Van der Werf, T S, Fijen, J W, Van de Merbel, N C, Spanjersberg, R, Möller, A V, Ligtenberg, J J, Tulleken, J E, Zijlstra, J G, Stegeman, C A
Publikováno v:
Intensive Care Medicine, 25(12), 1427-1431. SPRINGER
OBJECTIVE: To study the cefpirome pharmacokinetics of patients with sepsis and multiple organ failure treated with CVVH. DESIGN: Measurements of serum and ultrafiltrate (UF) concentrations and in vitro sensitivity testing of isolated micro-organisms.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::f45e95d7ed0ce61802ce71c3a4435078
https://research.rug.nl/en/publications/853bd088-c94b-4f80-b13a-b7ac37a68db0
https://research.rug.nl/en/publications/853bd088-c94b-4f80-b13a-b7ac37a68db0
Autor:
Hayes R; MPI Research, Mattawan, MI, USA., LeLacheur R; Agilux Laboratories, Worcester, MA, USA., Dumont I; Algorithme Pharma, Laval, QC, Canada., Couerbe P; Atlanbio, Saint-Nazaire, France., Safavi A; BioAgilytix, Durham, NC, USA., Islam R; Celerion, Lincoln, NB, USA., Pattison C; Charles River, Edinburgh, UK., Cape S; Covance, Madison, WI, USA., Rocci M; ICON, Whitesboro, NY, USA., Briscoe C; PRA Health Sciences, Lenexa, KS, USA., Cojocaru L; Tandem Labs, West Trenton, NJ, USA, currently at Covance, WestTrenton, NJ, USA., Groeber E; WIL Research, Ashland, OH, USA., Silvestro L; 3S-Pharmacological Cons. & Res. GmbH, Harpstedt, Germany., Bravo J; Agilux Laboratories, Worcester, MA, USA., Shoup R; AIT Bioscience Indianapolis, IN, USA., Verville M; Algorithme Pharma, Laval, QC, Canada., Zimmer J; Alturas Analytics, Moscow, ID, USA., Caturla MC; Anapharm Europe, Barcelona, Spain., Khadang A; Axis Clinicals, Dilworth, MN, USA., Bourdage J; BASi, West Lafayette, IN, USA., Hughes N; Bioanalytical Laboratory Services, Toronto, ON, Canada., Fatmi S; Biotrial Bioanalytical Services Inc., Laval, QC, Canada., Di Donato L; CAPRION, Montreal, QC, Canada., Sheldon C; Celerion, Lincoln, NB, USA., Keyhani A; Charles River, Senneville, QC, CAN, currently at Algorithme Pharma, Laval, QC, Canada., Satterwhite C; Charles River, Reno, NV, USA., Yu M; CIRION BioPharma Research, Laval, QC, Canada., Fiscella M; Covance, Chantilly, VA, USA., Hulse J; Eurofins Pharma Bioanalytics Services, St Charles, MO, USA., Lin ZJ; Frontage Laboratories, Inc., Exton, PA, USA., Garofolo W; Global CRO Council for Bioanalysis (GCC)., Savoie N; Global CRO Council for Bioanalysis (GCC)., Xiao YQ; Global CRO Council for Bioanalysis, Envigo, East Millstone, NJ, USA., Kurylak K; Global CRO Council for Bioanalysis, Envigo, East Millstone, NJ, USA., Harris S; Intertek USA, San Diego, CA, USA., Saxena M; Intertek USA, San Diego, CA, USA., Buonarati M; Intertek USA, San Diego, CA, USA., Lévesque A; Previously at InVentiv Health Clinical, Quebec City, QC, CAN., Boudreau N; Previously at InVentiv Health Clinical, Quebec City, QC, CAN., Lin J; CMIC, Inc., Hoffman Estates, IL, USA., Khan MU; KCAS Bioanalytical Services, Shawnee, KS, USA, currently at Alliance Pharma, Malvern, PA, USA., Ray G; KCAS Bioanalytical Services, Shawnee, KS, USA., Liu Y; KCAS Bioanalytical Services, Shawnee, KS, USA., Xu A; Keystone Bioanalytical, Inc., North Wales, PA, USA., Soni G; Lambda Therapeutic Research, Ahmedabad, India., Ward I; LGC, Fordham, UK., Kingsley C; LGC, Fordham, UK., Ritzén H; Mercodia AB, Uppsala, Sweden., Tabler E; PPD, Richmond, VA, USA., Nicholson B; PPD, Richmond, VA, USA., Bennett P; PPD, Richmond, VA, USA., van de Merbel N; PRA Health Sciences, Assen, The Netherlands., Karnik S; Pyxant Labs, Colorado Springs, CO, USA., Bouhajib M; Pharma Medica, Toronto, ON, Canada., Wieling J; QPS, Groningen, The Netherlands, currently at Antaeus Biopharma, Groningen, Netherlands., Mulvana D; Quintiles, Ithaca, NY, USA., Ingelse B; Quintiles, Oss, The Netherlands., Allen M; Tandem Labs, Durham, NC, USA, currently at Covance, Durham, NC, USA., Malone M; Worldwide Clinical Trials, Austin, TX, USA., Fang X; WuXi/XBL, 107 Morgan Lane, Plainsboro, NJ, USA.
Publikováno v:
Bioanalysis [Bioanalysis] 2016 Mar; Vol. 8 (6), pp. 487-95. Date of Electronic Publication: 2016 Feb 26.
Autor:
Tang C; Janssen Vaccines & Prevention, Leiden, The Netherlands., Verwilligen A; Janssen Vaccines & Prevention, Leiden, The Netherlands., Sadoff J; Janssen Vaccines & Prevention, Leiden, The Netherlands., Brandenburg B; Janssen Vaccines & Prevention, Leiden, The Netherlands., Sneekes-Vriese E; Janssen Vaccines & Prevention, Leiden, The Netherlands., van den Kerkhof T; Janssen Vaccines & Prevention, Leiden, The Netherlands., Dillen L; Janssen Research & Development, Beerse, Belgium., Rutten L; Janssen Vaccines & Prevention, Leiden, The Netherlands., Juraszek J; Janssen Vaccines & Prevention, Leiden, The Netherlands., Callewaert K; Janssen Research & Development, Beerse, Belgium., Janssen S; Janssen Vaccines & Prevention, Leiden, The Netherlands., Huizingh J; Janssen Vaccines & Prevention, Leiden, The Netherlands., Euler Z; Janssen Vaccines & Prevention, Leiden, The Netherlands., Schilperoord T; Janssen Vaccines & Prevention, Leiden, The Netherlands., Verhemeldonck M; Janssen Research & Development, Beerse, Belgium., Langedijk JPM; Janssen Vaccines & Prevention, Leiden, The Netherlands., Hendriks J; Janssen Vaccines & Prevention, Leiden, The Netherlands., Stieh DJ; Janssen Vaccines & Prevention, Leiden, The Netherlands. dstieh@vax.co.; Vaccine Company, Inc., South San Francisco, CA, USA. dstieh@vax.co.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2024 Jan 06; Vol. 9 (1), pp. 8. Date of Electronic Publication: 2024 Jan 06.
Autor:
Milosheska, Daniela1 (AUTHOR), Roškar, Robert1 (AUTHOR) robert.roskar@ffa.uni-lj.si
Publikováno v:
Molecules. Dec2023, Vol. 28 Issue 23, p7830. 15p.